136 related articles for article (PubMed ID: 1351322)
1. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance.
Takeuchi T; Lowry RP; Konieczny B
Transplantation; 1992 Jun; 53(6):1281-94. PubMed ID: 1351322
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
[TBL] [Abstract][Full Text] [Related]
4. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
5. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
[TBL] [Abstract][Full Text] [Related]
6. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.
Onodera K; Hancock WW; Graser E; Lehmann M; Sayegh MH; Strom TB; Volk HD; Kupiec-Weglinski JW
J Immunol; 1997 Feb; 158(4):1572-81. PubMed ID: 9029092
[TBL] [Abstract][Full Text] [Related]
7. Persistent infiltration of CD45RC- CD4+ T cells, Th2-like effector cells, in prolonging hepatic allografts in rats pretreated with a donor-specific blood transfusion.
Miyanari N; Yamaguchi Y; Matsuno K; Tominaga A; Goto M; Ichiguchi O; Mori K; Ogawa M
Hepatology; 1997 Apr; 25(4):1008-13. PubMed ID: 9096612
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
Wang J; Zhang L; Tang J; Jiang S; Wang X
Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
[TBL] [Abstract][Full Text] [Related]
9. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
[TBL] [Abstract][Full Text] [Related]
10. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
11. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.
Chan SY; DeBruyne LA; Goodman RE; Eichwald EJ; Bishop DK
Transplantation; 1995 Apr; 59(8):1155-61. PubMed ID: 7732563
[TBL] [Abstract][Full Text] [Related]
12. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
[TBL] [Abstract][Full Text] [Related]
13. Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice.
Morris CF; Simeonovic CJ; Fung MC; Wilson JD; Hapel AJ
J Immunol; 1995 Mar; 154(5):2470-82. PubMed ID: 7868913
[TBL] [Abstract][Full Text] [Related]
14. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
15. CD4 Th2 cells do not functionally suppress CTL generation in neonatal tolerant mice.
Gao Q; Chen N; Field EH
Transplantation; 1995 Dec; 60(11):1260-8. PubMed ID: 8525520
[TBL] [Abstract][Full Text] [Related]
16. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
Kupiec-Weglinski JW; Wasowska B; Papp I; Schmidbauer G; Sayegh MH; Baldwin WM; Wieder KJ; Hancock WW
J Immunol; 1993 Nov; 151(9):5053-61. PubMed ID: 8409456
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of murine B cell Fc gamma RII expression by CD4+ T helper subsets.
Snapper CM; Hooley JJ; Atasoy U; Finkelman FD; Paul WE
J Immunol; 1989 Oct; 143(7):2133-41. PubMed ID: 2528589
[TBL] [Abstract][Full Text] [Related]
18. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
[TBL] [Abstract][Full Text] [Related]
19. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
[TBL] [Abstract][Full Text] [Related]
20. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
